KR0177821B1 - Pharmaceutical compositions containing 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans - Google Patents

Pharmaceutical compositions containing 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans Download PDF

Info

Publication number
KR0177821B1
KR0177821B1 KR1019910700768A KR910700768A KR0177821B1 KR 0177821 B1 KR0177821 B1 KR 0177821B1 KR 1019910700768 A KR1019910700768 A KR 1019910700768A KR 910700768 A KR910700768 A KR 910700768A KR 0177821 B1 KR0177821 B1 KR 0177821B1
Authority
KR
South Korea
Prior art keywords
humans
malignant tumours
treatment
pharmaceutical compositions
derivatives
Prior art date
Application number
KR1019910700768A
Other languages
English (en)
Korean (ko)
Other versions
KR920700636A (ko
Inventor
Thornes R Douglas
Helga Stolze
Ernest Marshall
Kurt Zaenker
Original Assignee
Prae Vomed Ges Fur Medaizinisc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prae Vomed Ges Fur Medaizinisc filed Critical Prae Vomed Ges Fur Medaizinisc
Publication of KR920700636A publication Critical patent/KR920700636A/ko
Application granted granted Critical
Publication of KR0177821B1 publication Critical patent/KR0177821B1/ko

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37Coumarins, e.g. psoralen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • External Artificial Organs (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Monitoring And Testing Of Nuclear Reactors (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1019910700768A 1989-11-24 1991-07-22 Pharmaceutical compositions containing 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans KR0177821B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3938902A DE3938902C1 (fr) 1989-11-24 1989-11-24
DEP3938902.2 1989-11-24

Publications (2)

Publication Number Publication Date
KR920700636A KR920700636A (ko) 1992-08-10
KR0177821B1 true KR0177821B1 (en) 1999-03-20

Family

ID=6394102

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910700768A KR0177821B1 (en) 1989-11-24 1991-07-22 Pharmaceutical compositions containing 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans

Country Status (11)

Country Link
EP (1) EP0455769B1 (fr)
JP (1) JP3053645B2 (fr)
KR (1) KR0177821B1 (fr)
AT (1) ATE128354T1 (fr)
AU (1) AU6739690A (fr)
BR (1) BR9007080A (fr)
CA (1) CA2045593C (fr)
DE (2) DE3938902C1 (fr)
DK (1) DK0455769T3 (fr)
FI (1) FI913531A0 (fr)
WO (1) WO1991007959A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2822379B1 (fr) * 2001-03-20 2007-06-15 Sederma Sa Compositions cosmetiques et dermopharmaceutiques contenant de l'umbelliferone
US7148252B2 (en) * 2001-10-03 2006-12-12 Signal Pharmaceuticals, Llc Use of benzopyranones for treating or preventing a primary brain cancer or a brain metastasis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003865A1 (fr) * 1984-03-01 1985-09-12 Casley Smith John Royle Traitement des oedemes a forte teneur en proteines chez les animaux

Also Published As

Publication number Publication date
CA2045593A1 (fr) 1991-05-25
FI913531A0 (fi) 1991-07-23
CA2045593C (fr) 2000-09-05
JP3053645B2 (ja) 2000-06-19
KR920700636A (ko) 1992-08-10
DE3938902C1 (fr) 1991-05-08
BR9007080A (pt) 1991-12-24
WO1991007959A1 (fr) 1991-06-13
AU6739690A (en) 1991-06-26
EP0455769A1 (fr) 1991-11-13
JPH04505020A (ja) 1992-09-03
EP0455769B1 (fr) 1995-09-27
ATE128354T1 (de) 1995-10-15
DE59009724D1 (de) 1995-11-02
DK0455769T3 (da) 1996-02-05

Similar Documents

Publication Publication Date Title
IT8419266A1 (it) Dispositivo per generare calore in tessuti" del corpo umano e procedimento di cenerazione di calore, particolarmente per la cura di tumori
IL107109A0 (en) Compounds for modifying drug resistance and pharmaceutical compositions containing the same
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
BG63122B1 (en) Compounds and methods for cancer treatment
NO169291C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktivt tetrapyrrol-amino-dicarboxylsyreaddukt
HK1022810A1 (en) Method of treating endothelial injury
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
MY164077A (en) Compositions and uses of et743 for treating cancer
FI963687A0 (fi) Hygieeniset ja kosmeettiset valmisteet ihosairauksien estämiseksi ja hoitamiseksi sekä menetelmä niiden valmistamiseksi
HUP9900905A2 (hu) D4-Vitamin származékok alkalmazása rák kezelésére szolgáló gyógyászati készítmények előállítására
MX9805705A (es) Compuestos biaromaticos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones.
AU1206292A (en) Therapeutic agents for the treatment of multidrug resistance to cancers
EP0347899A3 (en) Pharmaceutical compositions on egg shell basis and their preparation and use
DE69521536D1 (de) Zusammensetzungen die G-CSF und ein TNF-Bindungsprotein enthalten
EP0281070A3 (fr) Composé pharmaceutique pour le traitement du cancer
ATE192923T1 (de) Verwendung von boswelliasäure zur behandlung von hirntumoren
ES8707488A1 (es) Un metodo para preparar maleato de 2-terc-butilamino-3'-cloropropiofenona
IL118218A (en) Pharmaceutical compositions containing sarcodictyins
KR0177821B1 (en) Pharmaceutical compositions containing 1,2-benzopyrone derivatives for the treatment of malignant tumours in humans
JPS57150618A (en) Anticancer
NZ331165A (en) Verotoxin pharmaceutical compositions and medical treatments therewith
DE3163920D1 (en) Pharmaceutical preparations comprising polyprenyl compounds, especially as anti-cancer agents, and pharmaceutical compositions for the prevention and treatment of cancer and skin diseases
EP0343671A3 (en) Pharmaceutical composition for the treatment of skin wounds
AU4042795A (en) Treatment of non-small cell lung carcinoma
ES2019713A6 (es) Un procedimiento para preparar derivados clorados de adenosina.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
N231 Notification of change of applicant
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20071107

Year of fee payment: 10

LAPS Lapse due to unpaid annual fee